Prolonged infusions of dexmedetomidine in critically ill patients
- 1 August 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 67 (15) , 1246-1253
Abstract
Purpose The efficacy and safety of dexmedetomidine when used longer than the manufacturer-recommended 24 hours were evaluated Summary Dexmedetomidine is the newest agent available for use in the critical care setting to induce and maintain sedation and analgesia. However, concerns over efficacy and safety during prolonged administration are a limiting factor for use in this patient population. A literature review was conducted to assess the clinical evidence regarding the efficacy and safety of dexmedetomidine for longer than 24 hours. A total of 11 studies were identified. Of these trials, 6 included adult patients and 5 included pediatric patients. Of the 6 adult trials, 3 comparative trials demonstrated a similar efficacy with benzodiazepines (i.e., midazolam and lorazepam) or propofol, with a reduction in the incidence of delirium and coma associated with dexmedetomidine. In noncomparative trials, dexmedetomidine was efficacious in achieving sedation goals with only mild adverse effects. In the 5 pediatric trials evaluated, efficacy to achieve a target sedation scale score could not be assessed, as most studies did not use validated sedation scales to measure goal sedation. Alternatively, the safety of dexmedetomidine has been demonstrated throughout an extended duration of use. In all of the studies evaluated, dexmedetomidine was associated with bradycardia; however, there were no reports of withdrawal effects, including rebound tachycardia and hypertension, upon discontinuation of dexmedetomidine infusion. Conclusion Dexmedetomidine is an alternative to traditional sedatives and analgesics in critically ill patients. The safety and efficacy of dexmedetomidine in adults likely persist beyond 24 hours, without the emergence of rebound effects after discontinuation.Keywords
This publication has 19 references indexed in Scilit:
- Dexmedetomidine vs Midazolam for Sedation of Critically Ill PatientsA Randomized TrialJAMA, 2009
- Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unitCardiology in the Young, 2009
- Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilationIntensive Care Medicine, 2008
- The Efficacy of Dexmedetomidine in Patients with Noninvasive Ventilation: A Preliminary StudyAnesthesia & Analgesia, 2008
- Use of dexmedetomidine for sedation of children hospitalized in the intensive care unitJournal of Hospital Medicine, 2008
- Use of Dexmedetomidine in the Pediatric Intensive Care UnitPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated PatientsJAMA, 2007
- Sedation Using Dexmedetomidine in Pediatric Burn PatientsJournal of Burn Care & Research, 2006
- Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effectsIntensive Care Medicine, 2004
- A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unitIntensive Care Medicine, 2003